i
Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay
-
Jan 09 2019
-
-
Source: J Infect Dis. 219(3):437-447
Details:
-
Alternative Title:J Infect Dis
-
Personal Author:
-
Description:Background.
Detection of Plasmodium antigens provides evidence of malaria infection status and is the basis for most malaria diagnosis.
Methods.
We developed a sensitive bead-based multiplex assay for laboratory use, which simultaneously detects pan-Plasmodium aldolase (pAldo), pan-Plasmodium lactate dehydrogenase (pLDH), and P. falciparum histidine-rich protein 2 (PfHRP2) antigens. The assay was validated against purified recombinant antigens, monospecies malaria infections, and noninfected blood samples. To test against samples collected in an endemic setting, Angolan outpatient samples (n = 1267) were assayed.
Results.
Of 466 Angolan samples positive for at least 1 antigen, the most common antigen profiles were PfHRP2+/pAldo+/pLDH+ (167, 36%), PfHRP2+/pAldo−/pLDH− (163, 35%), and PfHRP2+/pAldo+/pLDH− (129, 28%). Antigen profile was predictive of polymerase chain reaction (PCR) positivity and parasite density. Eight Angolan samples (1.7%) had no or very low PfHRP2 but were positive for 1 or both of the other antigens. PCR analysis confirmed 3 (0.6%) were P. ovale infections and 2 (0.4%) represented P. falciparum parasites lacking Pfhrp2 and/or Pfhrp3.
Conclusions.
These are the first reports of Pfhrp2/3 deletion mutants in Angola. High-throughput multiplex antigen detection can inexpensively screen for low-density P. falciparum, non-falciparum, and Pfhrp2/3-deleted parasites to provide population-level antigen estimates and identify specimens requiring further molecular characterization.
-
Subjects:
-
Source:
-
Pubmed ID:30202972
-
Pubmed Central ID:PMC6325347
-
Document Type:
-
Funding:
-
Volume:219
-
Issue:3
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: